These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 9316838)
1. BMS-190394, a selectin inhibitor, prevents rat cutaneous inflammatory reactions. Todderud G; Nair X; Lee D; Alford J; Davern L; Stanley P; Bachand C; Lapointe P; Marinier A; Martel A; Menard M; Wright JJ; Bajorath J; Hollenbaugh D; Aruffo A; Tramposch KM J Pharmacol Exp Ther; 1997 Sep; 282(3):1298-304. PubMed ID: 9316838 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of a novel synthetic selectin blocker, OJ-R9188, in allergic dermatitis. Ikegami-Kuzuhara A; Yoshinaka T; Ohmoto H; Inoue Y; Saito T Br J Pharmacol; 2001 Dec; 134(7):1498-504. PubMed ID: 11724756 [TBL] [Abstract][Full Text] [Related]
3. P-selectin glycoprotein ligand-1 is required for the development of cutaneous vasculitis induced by immune complex deposition. Yanaba K; Komura K; Horikawa M; Matsushita Y; Takehara K; Sato S J Leukoc Biol; 2004 Aug; 76(2):374-82. PubMed ID: 15123773 [TBL] [Abstract][Full Text] [Related]
4. Role of selectins on IgE-mediated skin reaction. Wada Y; Kuzuhara A; Hanamura M; Kida R; Yoshinaka T; Saito T Br J Pharmacol; 2000 Dec; 131(8):1531-6. PubMed ID: 11139428 [TBL] [Abstract][Full Text] [Related]
5. Exogenous application of hydrogen sulfide donor attenuates inflammatory reactions through the L-selectin-involved pathway in the cutaneous reverse passive Arthus reaction. Shimizu K; Ogawa F; Hara T; Yoshizaki A; Muroi E; Yanaba K; Akiyama Y; Yamaoka T; Sato S J Leukoc Biol; 2013 Apr; 93(4):573-84. PubMed ID: 23381473 [TBL] [Abstract][Full Text] [Related]
6. Affinity and kinetics of sialyl Lewis-X and core-2 based oligosaccharides binding to L- and P-selectin. Beauharnois ME; Lindquist KC; Marathe D; Vanderslice P; Xia J; Matta KL; Neelamegham S Biochemistry; 2005 Jul; 44(27):9507-19. PubMed ID: 15996105 [TBL] [Abstract][Full Text] [Related]
7. Selectin-blocking semisynthetic sulfated polysaccharides as promising anti-inflammatory agents. Höpfner M; Alban S; Schumacher G; Rothe U; Bendas G J Pharm Pharmacol; 2003 May; 55(5):697-706. PubMed ID: 12831514 [TBL] [Abstract][Full Text] [Related]
8. Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitis. Mollinedo F; Gajate C; Morales AI; del Canto-Jañez E; Justies N; Collía F; Rivas JV; Modolell M; Iglesias A J Pharmacol Exp Ther; 2009 May; 329(2):439-49. PubMed ID: 19244550 [TBL] [Abstract][Full Text] [Related]
9. Differential role of selectins in experimental colitis. Sans M; Salas A; Soriano A; Prats N; Gironella M; Pizcueta P; Elena M; Anderson DC; Piqué JM; Panés J Gastroenterology; 2001 Apr; 120(5):1162-72. PubMed ID: 11266380 [TBL] [Abstract][Full Text] [Related]
10. Contribution of endothelial selectins and alpha 4 integrins to eosinophil trafficking in allergic and nonallergic inflammatory reactions in skin. Teixeira MM; Hellewell PG J Immunol; 1998 Sep; 161(5):2516-23. PubMed ID: 9725251 [TBL] [Abstract][Full Text] [Related]
11. [The adherence of leukocytes mediated by L-selectin to endothelia activated by burn sera]. Ni J; Liu Z; Chen Y Zhonghua Shao Shang Za Zhi; 2001 Aug; 17(4):234-5. PubMed ID: 11876949 [TBL] [Abstract][Full Text] [Related]
12. Sulfatide binding and activation of leukocytes through an L-selectin-independent pathway. Ding Z; Kawashima H; Miyasaka M J Leukoc Biol; 2000 Jul; 68(1):65-72. PubMed ID: 10914491 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo selectin-blocking activities of sulfated lipids and sulfated sialyl compounds. Mulligan MS; Warner RL; Lowe JB; Smith PL; Suzuki Y; Miyasaka M; Yamaguchi S; Ohta Y; Tsukada Y; Kiso M; Hasegawa A; Ward PA Int Immunol; 1998 May; 10(5):569-75. PubMed ID: 9645605 [TBL] [Abstract][Full Text] [Related]
14. NPC 15669 inhibits the reversed passive Arthus reaction in rats by blocking neutrophil recruitment. Burch RM; Connor JR; Bator JM; Weitzberg M; Laemont K; Noronha-Blob L; Sullivan JP; Steranka LR J Pharmacol Exp Ther; 1992 Dec; 263(3):933-7. PubMed ID: 1469649 [TBL] [Abstract][Full Text] [Related]
15. Synthetic glycoprotein mimics inhibit L-selectin-mediated rolling and promote L-selectin shedding. Mowery P; Yang ZQ; Gordon EJ; Dwir O; Spencer AG; Alon R; Kiessling LL Chem Biol; 2004 May; 11(5):725-32. PubMed ID: 15157883 [TBL] [Abstract][Full Text] [Related]
16. E-selectin blockade decreases adventitial inflammation and attenuates intimal hyperplasia in rat carotid arteries after balloon injury. Gotoh R; Suzuki J; Kosuge H; Kakuta T; Sakamoto S; Yoshida M; Isobe M Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2063-8. PubMed ID: 15388522 [TBL] [Abstract][Full Text] [Related]
17. E- and P-selectin: differences, similarities and implications for the design of P-selectin antagonists. Binder FP; Ernst B Chimia (Aarau); 2011; 65(4):210-3. PubMed ID: 21678763 [TBL] [Abstract][Full Text] [Related]
18. Rational design of novel, potent small molecule pan-selectin antagonists. Kranich R; Busemann AS; Bock D; Schroeter-Maas S; Beyer D; Heinemann B; Meyer M; Schierhorn K; Zahlten R; Wolff G; Aydt EM J Med Chem; 2007 Mar; 50(6):1101-15. PubMed ID: 17302397 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of sulphated hyaluronic acid, a potential selectin-blocking agent, on experimental progressive mesangial proliferative glomerulonephritis. Matsuda M; Shikata K; Shimizu F; Suzuki Y; Miyasaka M; Kawachi H; Kawashima H; Wada J; Sugimoto H; Shikata Y; Ogawa D; Tojo SJ; Akima K; Makino H J Pathol; 2002 Nov; 198(3):407-14. PubMed ID: 12375274 [TBL] [Abstract][Full Text] [Related]
20. E-selectin, but not P-selectin, is required for development of adjuvant-induced arthritis in the rat. Issekutz AC; Mu JY; Liu G; Melrose J; Berg EL Arthritis Rheum; 2001 Jun; 44(6):1428-37. PubMed ID: 11407705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]